Swiss All Share Index
16.669,46
PKT
+61,82
PKT
+0,37
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.11.12 | Swiss Life buy | Sarasin Research | |
| 27.11.12 | Nestlé kaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.11.12 | Swiss Prime Site hold | Vontobel Research | |
| 27.11.12 | PSP Swiss Property hold | Vontobel Research | |
| 27.11.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.11.12 | Meyer Burger Technology reduce | Sarasin Research | |
| 26.11.12 | Straumann hold | Vontobel Research | |
| 26.11.12 | Lonza hold | Vontobel Research | |
| 26.11.12 | Swiss Re neutral | Sarasin Research | |
| 26.11.12 | UBS neutral | Macquarie Research | |
| 26.11.12 | Sulzer buy | Vontobel Research | |
| 26.11.12 | Swiss Re buy | Vontobel Research | |
| 26.11.12 | Straumann neutral | Sarasin Research | |
| 26.11.12 | Richemont buy | Sarasin Research | |
| 23.11.12 | Clariant buy | UBS AG | |
| 23.11.12 | ARYZTA buy | UBS AG | |
| 23.11.12 | Sonova kaufen | Fuchsbriefe | |
| 23.11.12 | Meyer Burger Technology reduce | Sarasin Research | |
| 23.11.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 22.11.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 22.11.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 22.11.12 | Holcim buy | UBS AG | |
| 22.11.12 | Holcim buy | UBS AG | |
| 22.11.12 | Meyer Burger Technology hold | Vontobel Research | |
| 22.11.12 | Swiss Life buy | UBS AG | |
| 22.11.12 | Holcim hold | Vontobel Research | |
| 22.11.12 | SHL Telemedicine buy | Vontobel Research | |
| 21.11.12 | Swatch (I) buy | Deutsche Bank AG | |
| 21.11.12 | UBS overweight | Morgan Stanley | |
| 21.11.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 21.11.12 | Novartis reduce | Vontobel Research | |
| 21.11.12 | Swiss Prime Site buy | Sarasin Research | |
| 21.11.12 | Meyer Burger Technology hold | Vontobel Research | |
| 21.11.12 | Swiss Prime Site hold | Vontobel Research | |
| 21.11.12 | DKSH hold | Vontobel Research | |
| 20.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 20.11.12 | UBS neutral | Exane-BNP Paribas SA | |
| 20.11.12 | UBS outperform | Exane-BNP Paribas SA | |
| 20.11.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 20.11.12 | Novartis buy | Sarasin Research |